What is the current annual EBITDA of GMED?

As of today, GMED annual EBITDA is $818.24M

What is 1-year change in GMED annual EBITDA?

GMED annual EBITDA is up +68.25% year-over-year

What is 3-year change in GMED annual EBITDA?

GMED annual EBITDA is up +168.58% over the past 3 years

How far is GMED annual EBITDA from its all-time high?

GMED annual EBITDA is currently at its all-time high

How does GMED annual EBITDA rank versus sector peers?

GMED annual EBITDA is higher than 92.42% of companies in Healthcare sector

When is GMED next annual earnings release?

As of today, the next annual earnings release for GMED has not been scheduled

What is the current quarterly EBITDA of GMED?

As of today, GMED quarterly EBITDA is $267.46M

What is GMED quarterly EBITDA most recent change?

GMED quarterly EBITDA was up +14.58% on June 30, 2026

What is 1-year change in GMED quarterly EBITDA?

GMED quarterly EBITDA is up +35.86% year-over-year

How far is GMED quarterly EBITDA from its all-time high?

GMED quarterly EBITDA is currently at its all-time high

How does GMED quarterly EBITDA rank versus sector peers?

GMED quarterly EBITDA is higher than 92.62% of companies in Healthcare sector

When is GMED next earnings release?

The next earnings release for GMED is on November 5, 2026

What is the current TTM EBITDA of GMED?

As of today, GMED TTM EBITDA is $957.98M

What is GMED TTM EBITDA most recent change?

GMED TTM EBITDA was up +7.96% on June 30, 2026

What is 1-year change in GMED TTM EBITDA?

GMED TTM EBITDA is up +50.86% year-over-year

How far is GMED TTM EBITDA from its all-time high?

GMED TTM EBITDA is currently at its all-time high

How does GMED TTM EBITDA rank versus sector peers?

GMED TTM EBITDA is higher than 92.72% of companies in Healthcare sector

When is GMED next earnings release?

The next earnings release for GMED is on November 5, 2026

GMED EBITDA History & Chart Since 2009

Annual EBITDA

$818.24M$331.90M+68.25%

December 31, 2025

Summary

Current Value: As of today, GMED annual EBITDA is $818.24M, up +68.25% on December 31, 2025
Historical Performance: GMED annual EBITDA is up +168.58% over the past 3 years, up +303.54% over the past 5 years
All-Time High Comparison: GMED annual EBITDA is currently at its all-time high
3-Year Low Comparison: GMED annual EBITDA is +168.58% above its 3-year low of $304.65M reached on an earlier date
Sector Comparison: GMED annual EBITDA is higher than 92.42% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

GMED Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$818.24M	+68.3%	+168.6%	+303.5%	+674.4%
Quarterly EBITDA	Jun 30, 26	$267.46M	+35.9%	+197.2%	+239.1%	+294.9%
TTM EBITDA	Jun 30, 26	$957.98M	+50.9%	+198.1%	+223.9%	+909.8%
Price	Aug 14, 26	$85.90	+43.1%	+49.4%	+12.4%	–
PE Ratio	Aug 14, 26	21.96	-5.2%	-23.4%	-48.1%	–
Annual Revenue	Dec 31, 25	$2.94B	+16.6%	+187.3%	+272.5%	+919.8%
Annual EPS	Dec 31, 25	$3.92	+425.4%	+111.8%	+287.4%	+554.1%
	Dec 31, 25	$540.76M	+132.8%	+128.8%	+286.6%	+497.7%
Annual Net Income	Dec 31, 25	$537.87M	+422.3%	+182.8%	+425.9%	+887.7%

EBITDA Highs

GMED Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$818.24M	Dec 31, 25	at high
5Y	$818.24M	Dec 31, 25	at high
All	$818.24M	Dec 31, 25	at high

EBITDA Lows

GMED Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$304.65M	N/A	+168.6%
5Y	$202.76M	N/A	+303.5%
All	$97.30M	Dec 31, 09	+741.0%

EBITDA History

Year	Value	Change
2025	$818.24M	+68.2%
2024	$486.34M	+40.3%
2023	$346.58M	+13.8%
2022	$304.65M	+1.9%
2021	$299.04M	+47.5%
2020	$202.76M	-11.6%
2019	$229.49M	+5.0%
2018	$218.51M	+4.7%
2017	$208.70M	+5.5%

Year	Value	Change
2016	$197.89M	-0.8%
2015	$199.42M	+21.1%
2014	$164.65M	+14.1%
2013	$144.25M	+9.2%
2012	$132.12M	+14.1%
2011	$115.78M	+9.6%
2010	$105.67M	+8.6%
2009	$97.30M	-

FAQ

What is the current annual EBITDA of GMED?: As of today, GMED annual EBITDA is $818.24M
What is 1-year change in GMED annual EBITDA?: GMED annual EBITDA is up +68.25% year-over-year
What is 3-year change in GMED annual EBITDA?: GMED annual EBITDA is up +168.58% over the past 3 years
How far is GMED annual EBITDA from its all-time high?: GMED annual EBITDA is currently at its all-time high
How does GMED annual EBITDA rank versus sector peers?: GMED annual EBITDA is higher than 92.42% of companies in Healthcare sector
When is GMED next annual earnings release?: As of today, the next annual earnings release for GMED has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$267.46M$34.03M+14.58%

June 30, 2026

Summary

Current Value: As of today, GMED quarterly EBITDA is $267.46M, up +14.58% on June 30, 2026
Historical Performance: GMED quarterly EBITDA is up +35.86% year-over-year, up +197.20% over the past 3 years
All-Time High Comparison: GMED quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: GMED quarterly EBITDA is +209.77% above its 3-year low of $86.34M reached on September 30, 2023
Sector Comparison: GMED quarterly EBITDA is higher than 92.62% of companies in Healthcare sector

Performance

GMED Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 30, 26	$267.46M	+14.6%	+35.9%	+197.2%	+239.1%
Annual EBITDA	Dec 31, 25	$818.24M	–	+68.3%	+168.6%	+303.5%
TTM EBITDA	Jun 30, 26	$957.98M	+8.0%	+50.9%	+198.1%	+223.9%
Price	Aug 14, 26	$85.90	+11.3%	+43.1%	+49.4%	+12.4%
PE Ratio	Aug 14, 26	21.96	+22.1%	-5.2%	-23.4%	-48.1%
Quarterly Revenue	Jun 30, 26	$789.61M	+3.9%	+5.9%	+170.8%	+214.6%
Quarterly EPS	Jun 30, 26	$1.10	+22.6%	-25.8%	+94.6%	+174.8%
	Jun 30, 26	$197.37M	+20.7%	+56.4%	+174.4%	+230.3%
Quarterly Net Income	Jun 30, 26	$151.57M	+21.9%	-25.3%	+162.6%	+264.8%

Quarterly EBITDA Highs

GMED Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$267.46M	Jun 30, 26	at high
3Y	$267.46M	Jun 30, 26	at high
5Y	$267.46M	Jun 30, 26	at high
All	$267.46M	Jun 30, 26	at high

Quarterly EBITDA Lows

GMED Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$196.86M	N/A	+35.9%
3Y	$86.34M	Sep 30, 23	+209.8%
5Y	$65.55M	Mar 31, 22	+308.0%
All	$14.19M	Jun 30, 20	+1784.7%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	$267.46M	+14.6%
Mar 2026	$233.43M	-7.1%
Dec 2025	$251.28M	+22.1%
Sep 2025	$205.81M	+4.5%
Jun 2025	$196.86M	+19.8%
Mar 2025	$164.29M	+4.0%
Dec 2024	$157.90M	+36.2%
Sep 2024	$115.95M	-9.2%
Jun 2024	$127.71M	+31.1%
Mar 2024	$97.39M	+0.3%
Dec 2023	$97.12M	+12.5%
Sep 2023	$86.34M	-4.1%
Jun 2023	$89.99M	+18.6%
Mar 2023	$75.87M	-3.8%
Dec 2022	$78.88M	+2.9%
Sep 2022	$76.63M	-8.3%
Jun 2022	$83.60M	+27.5%
Mar 2022	$65.55M	-15.1%
Dec 2021	$77.23M	+8.7%
Sep 2021	$71.05M	-9.9%
Jun 2021	$78.88M	+9.7%
Mar 2021	$71.89M	-7.1%
Dec 2020	$77.41M	+14.6%
Sep 2020	$67.58M	+376.2%
Jun 2020	$14.19M	-67.4%
Mar 2020	$43.56M	-33.9%
Dec 2019	$65.92M	+14.0%
Sep 2019	$57.82M	+3.6%
Jun 2019	$55.83M	+11.9%
Mar 2019	$49.91M	-18.8%
Dec 2018	$61.46M	+25.3%

Month	Value	Change
Sep 2018	$49.03M	-6.9%
Jun 2018	$52.68M	-4.8%
Mar 2018	$55.35M	-3.7%
Dec 2017	$57.49M	+16.2%
Sep 2017	$49.46M	+1.1%
Jun 2017	$48.93M	-7.6%
Mar 2017	$52.94M	-1.1%
Dec 2016	$53.54M	+14.7%
Sep 2016	$46.68M	-2.7%
Jun 2016	$48.00M	-3.1%
Mar 2016	$49.53M	-2.3%
Dec 2015	$50.71M	+8.4%
Sep 2015	$46.79M	+8.0%
Jun 2015	$43.31M	-2.1%
Mar 2015	$44.23M	-6.1%
Dec 2014	$47.11M	+16.8%
Sep 2014	$40.34M	+5.4%
Jun 2014	$38.26M	-4.5%
Mar 2014	$40.07M	-3.9%
Dec 2013	$41.68M	+21.4%
Sep 2013	$34.33M	-3.2%
Jun 2013	$35.46M	+4.6%
Mar 2013	$33.89M	+0.5%
Dec 2012	$33.73M	+6.4%
Sep 2012	$31.70M	-6.6%
Jun 2012	$33.93M	+3.6%
Mar 2012	$32.75M	-55.3%
Dec 2011	$73.25M	+2.5%
Sep 2011	$71.46M	+5.5%
Jun 2011	$67.72M	+149.5%
Mar 2011	$27.15M	-

FAQ

What is the current quarterly EBITDA of GMED?: As of today, GMED quarterly EBITDA is $267.46M
What is GMED quarterly EBITDA most recent change?: GMED quarterly EBITDA was up +14.58% on June 30, 2026
What is 1-year change in GMED quarterly EBITDA?: GMED quarterly EBITDA is up +35.86% year-over-year
How far is GMED quarterly EBITDA from its all-time high?: GMED quarterly EBITDA is currently at its all-time high
How does GMED quarterly EBITDA rank versus sector peers?: GMED quarterly EBITDA is higher than 92.62% of companies in Healthcare sector
When is GMED next earnings release?: The next earnings release for GMED is on November 5, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$957.98M$70.60M+7.96%

June 30, 2026

Summary

Current Value: As of today, GMED TTM EBITDA is $957.98M, up +7.96% on June 30, 2026
Historical Performance: GMED TTM EBITDA is up +50.86% year-over-year, up +198.09% over the past 3 years
All-Time High Comparison: GMED TTM EBITDA is currently at its all-time high
3-Year Low Comparison: GMED TTM EBITDA is +198.09% above its 3-year low of $321.37M reached on an earlier date
Sector Comparison: GMED TTM EBITDA is higher than 92.72% of companies in Healthcare sector

Performance

GMED Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 30, 26	$957.98M	+8.0%	+50.9%	+198.1%	+223.9%
Annual EBITDA	Dec 31, 25	$818.24M	–	+68.3%	+168.6%	+303.5%
Quarterly EBITDA	Jun 30, 26	$267.46M	+14.6%	+35.9%	+197.2%	+239.1%
Price	Aug 14, 26	$85.90	+11.3%	+43.1%	+49.4%	+12.4%
PE Ratio	Aug 14, 26	21.96	+22.1%	-5.2%	-23.4%	-48.1%
TTM Revenue	Jun 30, 26	$3.14B	+1.4%	+19.7%	+186.7%	+238.9%
TTM EPS	Jun 30, 26	$3.91	-8.9%	+50.9%	+95.0%	+116.5%
	Jun 30, 26	$677.26M	+11.7%	+86.5%	+170.2%	+199.3%
TTM Net Income	Jun 30, 26	$535.43M	-8.7%	+50.1%	+162.0%	+190.9%

TTM EBITDA Highs

GMED TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$957.98M	Jun 30, 26	at high
3Y	$957.98M	Jun 30, 26	at high
5Y	$957.98M	Jun 30, 26	at high
All	$957.98M	Jun 30, 26	at high

TTM EBITDA Lows

GMED TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$634.99M	N/A	+50.9%
3Y	$321.37M	N/A	+198.1%
5Y	$292.70M	Mar 31, 22	+227.3%
All	$27.15M	Mar 31, 11	+3428.8%

TTM EBITDA History

Month	Value	Change
Jun 2026	$957.98M	+8.0%
Mar 2026	$887.38M	+8.4%
Dec 2025	$818.24M	+12.9%
Sep 2025	$724.86M	+14.2%
Jun 2025	$634.99M	+12.2%
Mar 2025	$565.84M	+13.4%
Dec 2024	$498.94M	+13.9%
Sep 2024	$438.16M	+7.2%
Jun 2024	$408.56M	+10.2%
Mar 2024	$370.84M	+6.2%
Dec 2023	$349.32M	+5.5%
Sep 2023	$331.09M	+3.0%
Jun 2023	$321.37M	+2.0%
Mar 2023	$314.98M	+3.4%
Dec 2022	$304.66M	+0.5%
Sep 2022	$303.00M	+1.9%
Jun 2022	$297.42M	+1.6%
Mar 2022	$292.70M	-2.1%
Dec 2021	$299.04M	-0.1%
Sep 2021	$299.22M	+1.2%
Jun 2021	$295.75M	+28.0%
Mar 2021	$231.07M	+14.0%
Dec 2020	$202.75M	+6.0%
Sep 2020	$191.25M	+5.4%
Jun 2020	$181.50M	-18.7%
Mar 2020	$223.14M	-2.8%
Dec 2019	$229.49M	+2.0%
Sep 2019	$225.02M	+4.1%
Jun 2019	$216.23M	+1.5%
Mar 2019	$213.08M	-2.5%
Dec 2018	$218.51M	+1.8%

Month	Value	Change
Sep 2018	$214.55M	-0.2%
Jun 2018	$214.97M	+1.8%
Mar 2018	$211.22M	+1.2%
Dec 2017	$208.81M	+1.9%
Sep 2017	$204.86M	+1.4%
Jun 2017	$202.08M	+0.5%
Mar 2017	$201.15M	+1.7%
Dec 2016	$197.74M	+1.4%
Sep 2016	$194.91M	-0.1%
Jun 2016	$195.03M	+2.5%
Mar 2016	$190.34M	+2.9%
Dec 2015	$185.04M	+2.0%
Sep 2015	$181.44M	+3.7%
Jun 2015	$174.99M	+3.0%
Mar 2015	$169.94M	+2.5%
Dec 2014	$165.78M	+3.4%
Sep 2014	$160.35M	+3.9%
Jun 2014	$154.34M	+1.8%
Mar 2014	$151.54M	+4.3%
Dec 2013	$145.36M	+5.8%
Sep 2013	$137.41M	+1.9%
Jun 2013	$134.79M	+1.1%
Mar 2013	$133.26M	+0.9%
Dec 2012	$132.12M	-23.0%
Sep 2012	$171.64M	-18.8%
Jun 2012	$211.39M	-13.8%
Mar 2012	$245.18M	+2.3%
Dec 2011	$239.58M	+44.0%
Sep 2011	$166.32M	+75.3%
Jun 2011	$94.87M	+249.5%
Mar 2011	$27.15M	-

FAQ

What is the current TTM EBITDA of GMED?: As of today, GMED TTM EBITDA is $957.98M
What is GMED TTM EBITDA most recent change?: GMED TTM EBITDA was up +7.96% on June 30, 2026
What is 1-year change in GMED TTM EBITDA?: GMED TTM EBITDA is up +50.86% year-over-year
How far is GMED TTM EBITDA from its all-time high?: GMED TTM EBITDA is currently at its all-time high
How does GMED TTM EBITDA rank versus sector peers?: GMED TTM EBITDA is higher than 92.72% of companies in Healthcare sector
When is GMED next earnings release?: The next earnings release for GMED is on November 5, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

GMED Official Website www.globusmedical.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1237831/000162828026011209/0001628280-26-011209-index.htm
GMED Profile on Yahoo Finance finance.yahoo.com/quote/GMED
GMED Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmed